
Sign up to save your podcasts
Or


When we think about medicine’s war on cancer, treatments such as surgery, radiation and chemotherapy spring to mind first. Now there is another potential weapon for defeating tumors: statistics and mathematical models that can optimize the selection, combination or timing of treatment. Building and feeding these models requires accounting for the complexity of the body, and recognizing that cancer cells are constantly evolving.
In this episode, host Steven Strogatz hears from Franziska Michor, a computational biologist, about how our understanding of evolutionary dynamics is being used to devise new anticancer therapies.
By Steven Strogatz, Janna Levin and Quanta Magazine4.9
482482 ratings
When we think about medicine’s war on cancer, treatments such as surgery, radiation and chemotherapy spring to mind first. Now there is another potential weapon for defeating tumors: statistics and mathematical models that can optimize the selection, combination or timing of treatment. Building and feeding these models requires accounting for the complexity of the body, and recognizing that cancer cells are constantly evolving.
In this episode, host Steven Strogatz hears from Franziska Michor, a computational biologist, about how our understanding of evolutionary dynamics is being used to devise new anticancer therapies.

301 Listeners

832 Listeners

558 Listeners

521 Listeners

252 Listeners

1,061 Listeners

77 Listeners

4,153 Listeners

2,337 Listeners

449 Listeners

499 Listeners

251 Listeners

318 Listeners

33 Listeners

391 Listeners

509 Listeners